The table below shows Beam Therapeutics Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$31.74M
$9.70M
$8.47M
$7.47M
$14.27M
$11.77M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$104.52M
$109.77M
$101.76M
$98.82M
$94.26M
$87.04M
SG&A
BEAM annual revenue (10-K history)
Beam Therapeutics Inc. reported annual revenue of $139.74M for fiscal year 2025. That is up 120.0% from $63.52M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $18.00K (FY 2019) to $139.74M. Figures come from the company's audited annual reports as filed with the SEC.
